Recent news on Abbokinase

ImaRx Therapeutics, Inc. Files Registration Statement for Initial ...  -  May 4, 2007
Genetic Engineering News (press release),ImaRx Therapeutics' commercialization efforts are currently focused on its product, Abbokinase(R), for the treatment of acute massive pulmonary embolism.

ASA: Intracranial Thrombolytics Prompt Dramatic Stroke Response  -  Feb 12, 2007
MedPage Today,Most were given tPA (78) while 27 received Abbokinase (urokinase) and three received pro-urokinase. Most patients had a middle cerebral arterial stroke (80)

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional